OTCPK:AVMR

Stock Analysis Report

Executive Summary

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • AVRA Medical Robotics has significant price volatility in the past 3 months.
  • AVRA Medical Robotics is not covered by any analysts.

Share Price & News

How has AVRA Medical Robotics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

AVMR

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

n/a

AVMR

9.5%

US Medical Equipment

1.1%

US Market

No trading data on AVMR.

No trading data on AVMR.


Share holder returns

AVMRIndustryMarket
7 Day0%0.7%-0.2%
30 Day-7.1%0.1%2.5%
90 Day-23.5%2.5%1.6%
1 Yearn/a10.4%9.5%3.4%1.1%
3 Yearn/a69.3%64.1%45.2%35.8%
5 Yearn/a138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is AVRA Medical Robotics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is AVRA Medical Robotics undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether AVRA Medical Robotics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as AVRA Medical Robotics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of AVMR’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through AVRA Medical Robotics regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is AVRA Medical Robotics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as AVRA Medical Robotics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of AVMR’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access AVRA Medical Robotics's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has AVRA Medical Robotics performed over the past 5 years?

-39.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

AVRA Medical Robotics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare AVRA Medical Robotics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare AVRA Medical Robotics's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if AVRA Medical Robotics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if AVRA Medical Robotics has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if AVRA Medical Robotics improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is AVRA Medical Robotics's financial position?


Financial Position Analysis

AVRA Medical Robotics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

AVRA Medical Robotics has no long term commitments.


Debt to Equity History and Analysis

AVRA Medical Robotics has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if AVRA Medical Robotics's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

AVRA Medical Robotics has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

AVRA Medical Robotics has less than a year of cash runway based on current free cash flow.

AVRA Medical Robotics has less than a year of cash runway if free cash flow continues to grow at historical rates of 20.4% each year.


Next Steps

Dividend

What is AVRA Medical Robotics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate AVRA Medical Robotics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate AVRA Medical Robotics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as AVRA Medical Robotics has not reported any payouts.

Unable to verify if AVRA Medical Robotics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as AVRA Medical Robotics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of AVRA Medical Robotics's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average management tenure


CEO

Barry Cohen (79yo)

4.6yrs

Tenure

US$186,000

Compensation

Mr. Barry F. Cohen serves as Chairman at AVRA Medical Robotics, Inc and has been its Chief Executive Officer since February 04, 2015. Mr. Cohen has been cting Chief Financial Officer at AVRA Medical Roboti ...


CEO Compensation Analysis

Barry's remuneration is lower than average for companies of similar size in United States of America.

Barry's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.9yrs

Average Tenure

57yo

Average Age

The tenure for the AVRA Medical Robotics management team is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Ray Powers (72yo)

    Chief Operating Officer

    • Tenure: 3.1yrs
  • Barry Cohen (79yo)

    Chairman

    • Tenure: 4.6yrs
    • Compensation: US$186.00k
  • Farhan Taghizadeh (47yo)

    Chief Medical Officer

    • Tenure: 2yrs
  • Nicole Bergman-Fong (57yo)

    Corporate Counsel

    • Tenure: 2.9yrs
  • Nikhil Shah (48yo)

    Chief Strategy Officer

    • Tenure: 1.5yrs

Board Members

  • Albert Schauer (76yo)

    Director

    • Tenure: 1.5yrs
  • Vipul Patel

    Member of the Medical Advisory Board

    • Tenure: 0yrs
  • Yuman Fong

    Member of the Medical Advisory Board

    • Tenure: 0yrs
  • Bijan Safai

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Hiep Nguyen

    Member of the Medical Advisory Board

    • Tenure: 0yrs
  • Barry Cohen (79yo)

    Chairman

    • Tenure: 4.6yrs
    • Compensation: US$186.00k
  • Peter Carnegie (49yo)

    Director

    • Tenure: 3.1yrs
  • Juan Badimon

    Member of the Medical Advisory Board

    • Tenure: 0yrs
  • Heywood Epstein

    Member of the Medical Advisory Board

    • Tenure: 0yrs
  • Jochen Binder

    Member of the Medical Advisory Board

    • Tenure: 0yrs

Company Information

AVRA Medical Robotics, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: AVRA Medical Robotics, Inc.
  • Ticker: AVMR
  • Exchange: OTCPK
  • Founded: 2015
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$41.939m
  • Shares outstanding: 21.51m
  • Website: https://www.avramedicalrobotics.com

Number of Employees


Location

  • AVRA Medical Robotics, Inc.
  • 3259 Progress Drive
  • Suite 112A
  • Orlando
  • Florida
  • 32826
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVMROTCPK (Pink Sheets LLC)YesCommon StockUSUSDJul 2018

Biography

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies wi ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:24
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.